热门资讯> 正文

United Therapeutics未能达到第一季度的预期

2026-05-06 18:38

联合治疗(UTHR) 0
TON(TON_USD.HASHKEY) 0

United Therapeutics press release (UTHR): Q1 GAAP EPS of $5.82 misses by $1.04.
Revenue of $781.5M (-1.6% Y/Y) misses by $15.88M.

More on United Therapeutics

United Therapeutics: The Future Lies With Manufactured Organs
United Therapeutics: Maintaining 'Strong Buy' On Second TETON Study Program Win
United Therapeutics: Ralinepag Is The Ultimate Defense Against Yutrepia (Rating Upgrade)
United Therapeutics Q1 2026 Earnings Preview
Smithfield Foods is the most overbought U.S. large-cap stock

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。